Y Combinator placing a bet on a new generation of biotech start-ups
Y Combinator, the well-known Silicon Valley accelerator, is betting that biotech start-ups that use the latest computer science technologies such as machine learning will grow much more quickly than their counterparts and, as a result, should be funded more like tech start-ups. Read more about the team’s thinking here.
